News of the WeekEUROPEAN PATENTS

BRCA2 Claim Faces New Challenge

See allHide authors and affiliations

Science  24 Jun 2005:
Vol. 308, Issue 5730, pp. 1851
DOI: 10.1126/science.308.5730.1851a

You are currently viewing the summary.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution

Summary

A patent on the breast cancer gene BRCA2 --a symbol of assertive U.S. biotechnology--faces a major challenge in the European Patent Office on 29 June.